Cargando…

Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer

Paclitaxel (PTX) is one of the most efficient drugs for late-stage non-small cell lung cancer (NSCLC) patients. However, most patients gradually develop resistance to PTX with long-term treatments. The identification of new strategies to reverse PTX resistance in NSCLC is crucially important for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Xiaxia, Wu, Ting, Yin, Qishuang, Gu, Xinsheng, Li, Gege, Zhou, Changlong, Ma, Mei, Su, Li, Tang, Shu, Tian, Yanan, Yang, Ming, Cui, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563422/ https://www.ncbi.nlm.nih.gov/pubmed/36231056 http://dx.doi.org/10.3390/cells11193094

Ejemplares similares

Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance
por: Niu, Xiaxia, et al.
Publicado: (2022)

Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3
por: Niu, Xiaxia, et al.
Publicado: (2022)

SPA70 is a potent antagonist of human pregnane X receptor
por: Lin, Wenwei, et al.
Publicado: (2017)

Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity
por: Shi, Xingjuan, et al.
Publicado: (2017)

CRM197 reverses paclitaxel resistance by inhibiting the NAC‐1/Gadd45 pathway in paclitaxel‐resistant ovarian cancer cells
por: Tang, Xiao‐han, et al.
Publicado: (2019)

Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice
por: Chen, Xi, et al.
Publicado: (2016)

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
por: Schirizzi, Annalisa, et al.
Publicado: (2023)

Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells
por: Fan, Li-li, et al.
Publicado: (2020)

Cold Atmospheric Plasma Restores Paclitaxel Sensitivity to Paclitaxel-Resistant Breast Cancer Cells by Reversing Expression of Resistance-Related Genes
por: Park, Sungbin, et al.
Publicado: (2019)

A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
por: Duan, Zhenfeng, et al.
Publicado: (2014)

No need for H(2)-antagonists in premedication regimens for paclitaxel infusions: less is more
por: Gelderblom, Hans, et al.
Publicado: (2021)

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
por: de Leon, Maria C.B., et al.
Publicado: (2013)

Ginsenoside Rg5 Sensitizes Paclitaxel—Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel—And Enhances the Anticancer Effect of Paclitaxel
por: Ramesh, Janani, et al.
Publicado: (2022)

Paclitaxel in Cancer Treatment
por: Kaye, SB
Publicado: (1996)

Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016)

Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)–paclitaxel nanoparticles
por: Yang, Danbo, et al.
Publicado: (2011)

Low temperature upregulating HSP70 expression to mitigate the paclitaxel-induced damages in NHEK cell
por: Chen, Liang, et al.
Publicado: (2023)

Bromodomain-containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2-antagonist/killer protein
por: Ma, Jinqi, et al.
Publicado: (2019)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
por: Lazzaro, Carlo, et al.
Publicado: (2013)

Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity
por: Jia, Min, et al.
Publicado: (2020)

Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
por: Chen, Nianhang, et al.
Publicado: (2015)

Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
por: Wang, Panpan, et al.
Publicado: (2020)

P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer
por: Liu, Zhaojun, et al.
Publicado: (2019)

Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells
por: Jiménez-Guerrero, Rocío, et al.
Publicado: (2018)

The Interface amongst Conserved and Specialized Pathways in Non-Paclitaxel and Paclitaxel Accumulating Taxus Cultures
por: McKee, Michelle C., et al.
Publicado: (2021)

PXR: a center of transcriptional regulation in cancer
por: Xing, Yaqi, et al.
Publicado: (2020)

Chidamide combined with paclitaxel effectively reverses the expression of histone deacetylase in lung cancer
por: Zhang, Na, et al.
Publicado: (2020)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients
por: Borgå, Olof, et al.
Publicado: (2019)

Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
por: He, Jing, et al.
Publicado: (2019)

Going Nuts over Paclitaxel
por: Susman, Ed
Publicado: (2000)

Biotinylated Cyclooligosaccharides for Paclitaxel Solubilization
por: Cho, Eunae, et al.
Publicado: (2018)

Paclitaxel: Pneumonia: case report
Publicado: (2020)

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer
por: Zhao, Meng-Dan, et al.
Publicado: (2019)

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
por: Hassan, Md Sazzad, et al.
Publicado: (2018)

Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles
por: Li, Jing, et al.
Publicado: (2019)

Palladium-Catalyzed Synthesis and Anticancer Activity of Paclitaxel–Dehydroepiandrosterone Hybrids
por: Lou, Sheng-Jie, et al.
Publicado: (2020)

Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel-sensitive cells via exosomal delivery of miR-155-5p
por: Wang, Mei, et al.
Publicado: (2018)

Histamine‐2 (H(2)) antagonists can be safely removed from standard paclitaxel premedication regimens
por: Foreman, Emma, et al.
Publicado: (2022)

Way to efficient microbial paclitaxel mass production
por: Li, Chenyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5361h03dgrft8jf280t8drsrqp